After two bouts of breast cancer and a double mastectomy, I wish I had taken that photo at 34, just for me to remember the ...

Daraxonrasib has received breakthrough therapy designation from the FDA for KRAS G12+, previously treated, metastatic ...

The START Hope Hub is a robust digital platform designed to break down barriers to early-phase clinical trial access for ...

Datroway received accelerated FDA approval for adults with EGFR+ advanced non-small cell lung cancer after EGFR-targeted and ...

After my breast cancer diagnosis, faith guided me through fear, and in passing on a blessed bracelet, I found healing and an ...

Kasey Rangan discusses ways that families of patients with pediatric brain cancer can advocate for themselves, especially when it comes to mental health.

After a brain tumor diagnosis and infection, I celebrate recovery with family at the beach, embracing life’s precious moments ...

Tripp Razor highlights the disproportionately high pancreatic cancer risk among Black Americans and the systemic disparities ...

Dr. Joshua Sabari and Dr. Nausheen Ahmed sat down to discuss topline takeaways in the realm of hematologic malignancies ...

ASCO Annual Meeting brought many different updates to light in the realm of hematological malignancies, including multiple ...

Dr. Michael Serzan emphasizes the importance of clinical trial participation for patients with kidney cancer.

FDA approved to help select patients with metastatic prostate cancer for radioligand therapy before chemotherapy.